MDT

96.58

+0.4%↑

A

137.28

-0.49%↓

VEEV

224.99

+0.5%↑

HQY

92.37

-0.06%↓

PHR.US

16.94

+0.18%↑

MDT

96.58

+0.4%↑

A

137.28

-0.49%↓

VEEV

224.99

+0.5%↑

HQY

92.37

-0.06%↓

PHR.US

16.94

+0.18%↑

MDT

96.58

+0.4%↑

A

137.28

-0.49%↓

VEEV

224.99

+0.5%↑

HQY

92.37

-0.06%↓

PHR.US

16.94

+0.18%↑

MDT

96.58

+0.4%↑

A

137.28

-0.49%↓

VEEV

224.99

+0.5%↑

HQY

92.37

-0.06%↓

PHR.US

16.94

+0.18%↑

MDT

96.58

+0.4%↑

A

137.28

-0.49%↓

VEEV

224.99

+0.5%↑

HQY

92.37

-0.06%↓

PHR.US

16.94

+0.18%↑

Search

West Pharmaceutical Services Inc

Aperta

SettoreSettore sanitario

276.21 0.37

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

273.53

Massimo

276.09

Metriche Chiave

By Trading Economics

Entrata

8.2M

140M

Vendite

38M

804M

P/E

Media del settore

40.664

78.892

EPS

1.96

Rendimento da dividendi

0.31

Margine di Profitto

17.406

Dipendenti

10,600

EBITDA

19M

217M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+27.12% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

0.31%

2.38%

Prossima data del Dividendo

4 feb 2026

Prossima data del' Ex Dividendo

28 gen 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

9.2M

20B

Apertura precedente

275.84

Chiusura precedente

276.21

Notizie sul Sentiment di mercato

By Acuity

34%

66%

86 / 374 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bullish Evidence

West Pharmaceutical Services Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

29 dic 2025, 22:03 UTC

I principali Market Mover

Mining Stocks Slip Near the End of Stellar Year

29 dic 2025, 15:57 UTC

I principali Market Mover

Praxis Shares Rise on Ulixacaltamide Breakthrough Designation

29 dic 2025, 23:43 UTC

Discorsi di Mercato

Nikkei May Decline; Yen in Focus -- Market Talk

29 dic 2025, 23:38 UTC

Acquisizioni, Fusioni, Takeovers

Manus: Will Continue to Operate From Singapore

29 dic 2025, 23:38 UTC

Acquisizioni, Fusioni, Takeovers

Manus: Will Continue to Sell, Operate Product Subscription Service Through App, Website

29 dic 2025, 23:37 UTC

Acquisizioni, Fusioni, Takeovers

Meta Platforms: Will Integrate Manus Service Into Products

29 dic 2025, 23:36 UTC

Acquisizioni, Fusioni, Takeovers

Meta Platforms: Will Continue to Operate, Sell Manus Service

29 dic 2025, 23:36 UTC

Acquisizioni, Fusioni, Takeovers

Meta Platforms: Manus's Talent to Join Team to Deliver General-Purpose Agents Across Consumer, Business Products

29 dic 2025, 23:35 UTC

Acquisizioni, Fusioni, Takeovers

Manus to Join Meta Platforms

29 dic 2025, 21:33 UTC

Acquisizioni, Fusioni, Takeovers

Origin: Raise Values Kraken at US$8.65 Billion

29 dic 2025, 21:33 UTC

Acquisizioni, Fusioni, Takeovers

Origin: Octopus Targeting Kraken Separation by Mid 2026

29 dic 2025, 21:31 UTC

Acquisizioni, Fusioni, Takeovers

BlueScope: Rezoning Will Allow for Range of Commercial, Industrial Development Uses

29 dic 2025, 21:31 UTC

Acquisizioni, Fusioni, Takeovers

BlueScope Also Says Land Adjacent to Port Kembla Steelworks Rezoned to Special Purpose

29 dic 2025, 21:30 UTC

Acquisizioni, Fusioni, Takeovers

Origin's Kraken Stake to Remain at 22.7%

29 dic 2025, 21:30 UTC

Acquisizioni, Fusioni, Takeovers

Origin Will Continue to Hold Its 22.7% Interest in Octopus

29 dic 2025, 21:30 UTC

Acquisizioni, Fusioni, Takeovers

BlueScope: Guidance Reflects Sustained Strength of Operating Performance in Recent Months

29 dic 2025, 21:30 UTC

Acquisizioni, Fusioni, Takeovers

Origin: Additional Interest Offsets Dilution From Raise

29 dic 2025, 21:30 UTC

Acquisizioni, Fusioni, Takeovers

BlueScope Doesn't Expect Material Impact on 1H Guidance Range

29 dic 2025, 21:29 UTC

Acquisizioni, Fusioni, Takeovers

Origin Waiving Australia Exclusivity to Kraken in Exchange for Additional 1.5% Equity Interest

29 dic 2025, 21:29 UTC

Acquisizioni, Fusioni, Takeovers

BlueScope Expects to Complete Property Sale for A$76 Million Consideration

29 dic 2025, 21:29 UTC

Acquisizioni, Fusioni, Takeovers

BlueScope Expects to Complete Property Sale in 2H of FY 2026

29 dic 2025, 21:28 UTC

Acquisizioni, Fusioni, Takeovers

BlueScope: Selling Residentially Zoned Land in West Dapto to Large Homebuilder

29 dic 2025, 21:28 UTC

Acquisizioni, Fusioni, Takeovers

Origin: Kraken's Raise Paves Way for Separation From Octopus Energy

29 dic 2025, 21:28 UTC

Acquisizioni, Fusioni, Takeovers

Origin: Kraken to Raise Total US$1 Billion From New, Existing Investors

29 dic 2025, 21:28 UTC

Acquisizioni, Fusioni, Takeovers

BlueScope Steel Exchanges Contracts for Sale of 33 Hectares of Land in West Dapto

29 dic 2025, 21:27 UTC

Acquisizioni, Fusioni, Takeovers

Origin Energy to Invest US$140M in Kraken's Standalone Equity Raise

29 dic 2025, 20:22 UTC

Discorsi di Mercato

Oil Rebounds As Russia-Ukraine War Seen Continuing -- Market Talk

29 dic 2025, 20:14 UTC

Discorsi di Mercato

U.S. Natural Gas Futures Rise As Front Month Expires -- Market Talk

29 dic 2025, 20:02 UTC

Acquisizioni, Fusioni, Takeovers

Union Pacific--Norfolk Southern Merger Targets Trucking Market Share -- Barrons.com

29 dic 2025, 17:36 UTC

Discorsi di Mercato

U.S. Natural Gas Inventories Swing to Deficit Vs. 5-Year Average -- Market Talk

Confronto tra pari

Modifica del prezzo

West Pharmaceutical Services Inc Previsione

Obiettivo di Prezzo

By TipRanks

27.12% in crescita

Previsioni per 12 mesi

Media 348.7 USD  27.12%

Alto 375 USD

Basso 285 USD

Basato su 12 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per West Pharmaceutical Services Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

12 ratings

10

Acquista

2

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

213.26 / 219.27Supporto e resistenza

A breve termine

Strong Bullish Evidence

A termine intermedio

Bearish Evidence

A lungo termine

Bearish Evidence

Sentiment

By Acuity

86 / 374 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
help-icon Live chat